458 related articles for article (PubMed ID: 27033238)
21. RAG1 co-expression signature identifies ETV6-RUNX1-like B-cell precursor acute lymphoblastic leukemia in children.
Chen D; Camponeschi A; Nordlund J; Marincevic-Zuniga Y; Abrahamsson J; Lönnerholm G; Fogelstrand L; Mårtensson IL
Cancer Med; 2021 Jun; 10(12):3997-4003. PubMed ID: 33987955
[TBL] [Abstract][Full Text] [Related]
22. Fusion of EML1 to ABL1 in T-cell acute lymphoblastic leukemia with cryptic t(9;14)(q34;q32).
De Keersmaecker K; Graux C; Odero MD; Mentens N; Somers R; Maertens J; Wlodarska I; Vandenberghe P; Hagemeijer A; Marynen P; Cools J
Blood; 2005 Jun; 105(12):4849-52. PubMed ID: 15713800
[TBL] [Abstract][Full Text] [Related]
23. Poor responses to tyrosine kinase inhibitors in a child with precursor B-cell acute lymphoblastic leukemia with SNX2-ABL1 chimeric transcript.
Masuzawa A; Kiyotani C; Osumi T; Shioda Y; Iijima K; Tomita O; Nakabayashi K; Oboki K; Yasuda K; Sakamoto H; Ichikawa H; Hata K; Yoshida T; Matsumoto K; Kiyokawa N; Mori T
Eur J Haematol; 2014 Mar; 92(3):263-7. PubMed ID: 24215620
[TBL] [Abstract][Full Text] [Related]
24. Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemia.
Geng H; Brennan S; Milne TA; Chen WY; Li Y; Hurtz C; Kweon SM; Zickl L; Shojaee S; Neuberg D; Huang C; Biswas D; Xin Y; Racevskis J; Ketterling RP; Luger SM; Lazarus H; Tallman MS; Rowe JM; Litzow MR; Guzman ML; Allis CD; Roeder RG; Müschen M; Paietta E; Elemento O; Melnick AM
Cancer Discov; 2012 Nov; 2(11):1004-23. PubMed ID: 23107779
[TBL] [Abstract][Full Text] [Related]
25. Genetic abnormalities associated with the t(12;21) and their impact in the outcome of 56 patients with B-precursor acute lymphoblastic leukemia.
Alvarez Y; Coll MD; Ortega JJ; Bastida P; Dastugue N; Robert A; Cervera J; Verdeguer A; Tasso M; Aventín A; Guitart M; Caballín MR
Cancer Genet Cytogenet; 2005 Oct; 162(1):21-9. PubMed ID: 16157196
[TBL] [Abstract][Full Text] [Related]
26. Personalized medicine in adult acute lymphoblastic leukemia.
Hoelzer D
Haematologica; 2015 Jul; 100(7):855-8. PubMed ID: 26130512
[No Abstract] [Full Text] [Related]
27. Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases.
Li JF; Dai YT; Lilljebjörn H; Shen SH; Cui BW; Bai L; Liu YF; Qian MX; Kubota Y; Kiyoi H; Matsumura I; Miyazaki Y; Olsson L; Tan AM; Ariffin H; Chen J; Takita J; Yasuda T; Mano H; Johansson B; Yang JJ; Yeoh AE; Hayakawa F; Chen Z; Pui CH; Fioretos T; Chen SJ; Huang JY
Proc Natl Acad Sci U S A; 2018 Dec; 115(50):E11711-E11720. PubMed ID: 30487223
[TBL] [Abstract][Full Text] [Related]
28. Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohort.
Virk H; Rana S; Sharma P; Bose PL; Yadav DD; Sachdeva MUS; Varma N; Trehan A; Lad D; Khadwal AR; Malhotra P; Sreedharanunni S
Ann Hematol; 2021 Aug; 100(8):2031-2041. PubMed ID: 34159401
[TBL] [Abstract][Full Text] [Related]
29. In vitro sensitivity to dasatinib in lymphoblasts from a patient with t(17;19)(q22;p13) gene rearrangement pre-B acute lymphoblastic leukemia.
Glover JM; Loriaux M; Tyner JW; Druker BJ; Chang BH
Pediatr Blood Cancer; 2012 Sep; 59(3):576-9. PubMed ID: 22038978
[TBL] [Abstract][Full Text] [Related]
30. Genomic landscape of pediatric B-other acute lymphoblastic leukemia in a consecutive European cohort.
Zaliova M; Stuchly J; Winkowska L; Musilova A; Fiser K; Slamova M; Starkova J; Vaskova M; Hrusak O; Sramkova L; Stary J; Zuna J; Trka J
Haematologica; 2019 Jul; 104(7):1396-1406. PubMed ID: 30630978
[TBL] [Abstract][Full Text] [Related]
31. t(8;22)/BCR-FGFR1 myeloproliferative disorder presenting as B-acute lymphoblastic leukemia: report of a case treated with sorafenib and review of the literature.
Wakim JJ; Tirado CA; Chen W; Collins R
Leuk Res; 2011 Sep; 35(9):e151-3. PubMed ID: 21628071
[No Abstract] [Full Text] [Related]
32. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
[TBL] [Abstract][Full Text] [Related]
33. How is the Ph-like signature being incorporated into ALL therapy?
Maese L; Tasian SK; Raetz EA
Best Pract Res Clin Haematol; 2017 Sep; 30(3):222-228. PubMed ID: 29050695
[TBL] [Abstract][Full Text] [Related]
34. CRLF2 and IKZF1 abnormalities in Mexican children with acute lymphoblastic leukemia and recurrent gene fusions: exploring surrogate markers of signaling pathways.
Moreno Lorenzana D; Juárez Velázquez MDR; Reyes León A; Martínez Anaya D; Hernández Monterde A; Salas Labadía C; Navarrete Meneses MDP; Zapata Tarrés M; Juárez Villegas L; Jarquín Ramírez B; Cárdenas Cardós R; Herrera Almanza M; Paredes Aguilera R; Pérez Vera P
J Pathol Clin Res; 2021 Jul; 7(4):410-421. PubMed ID: 33890726
[TBL] [Abstract][Full Text] [Related]
35. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
36. A surrogate molecular approach for the detection of Philadelphia chromosome-like B-acute lymphoblastic leukemia.
Gupta DG; Varma N; Abdulkadir SA; Sreedharanunni S; Sachdeva MUS; Naseem S; Bose P; Binota J; Malhotra P; Khadwal A; Trehan A; Varma S
Cancer; 2024 Mar; 130(5):713-726. PubMed ID: 37819686
[TBL] [Abstract][Full Text] [Related]
37. Acute Lymphoblastic Leukemia With INPP5D-ABL1 Fusion Responds to Imatinib Treatment.
Poukka M; Lund-Aho T; Raittinen P; Nikkilä A; Kivinen K; Lundán T; Porkka K; Lohi O
J Pediatr Hematol Oncol; 2019 Oct; 41(7):e481-e483. PubMed ID: 30045148
[TBL] [Abstract][Full Text] [Related]
38. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
39. ETV6-RUNX1 interacts with a region in SPIB intron 1 to regulate gene expression in pre-B-cell acute lymphoblastic leukemia.
Xu LS; Francis A; Turkistany S; Shukla D; Wong A; Batista CR; DeKoter RP
Exp Hematol; 2019 May; 73():50-63.e2. PubMed ID: 30986496
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of ruxolitinib in B-lymphoblastic leukaemia with the PCM1-JAK2 fusion gene.
Wouters Y; Nevejan L; Louwagie A; Devos H; Dewaele B; Selleslag D; Michaux L
Br J Haematol; 2021 Feb; 192(4):e112-e115. PubMed ID: 33502001
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
